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Although the active immunization of monkeys against poliomyelitis 
has been attempted many times with attenuated and chemically inac- 
tivated  poliomyelitis virus (Landsteiner and Levaditi (1), Kraus (2), 
Zappert et al. (3), Abramson and Gerber (4)), success has been achieved 
only with living v.irus  (Flexner  and  Lewis  (5), Aycock and Kagan 
(6),  Stewart and Rhoads  (7), Rhoads (8)).  However, the danger of 
infection occurring during the  course of  treatment is  ever present, 
(Thomson  (9),  Aycock and Kagan  (5)).  Therefore, the purpose of 
this work was to attempt active immunization with active virus,  ob- 
tained  from  monkeys prostrate  with  poliomyelitis, in  from  6  to 8 
days, together with sufficient human convalescent serum to add to the 
safety of the method. 
Flexner and  Lewis  (5)  were the  first  to  confer  active immunity 
against poliomyelitis to monkeys.  They used subcutaneous injections 
of active poliomyelitis virus emulsion.  Later Aycock and Kagan (6) 
used the intradermal route with success,  while Stewart and Rhoads 
(7), in their experiments, found the intracutaneous injection superior 
to  the subcutaneous for immunization. 
A combination of immune serum and virus was used by Romer and 
Joseph  (10, 11)  and  by  Thompson  (12),  but  the  only  serious  at- 
tempt to produce active immunization with such material was made 
by Rhoads  (13).  He used equal parts of 5 per cent virus emulsion 
and immune serum, that had been in contact an hour.  Several series 
of  animals  were  treated  subcutaneously  and  intradermally,  either 
with two large injections, or multiple small inoculations. 
* This  research  was  made  possible  through  the  generosity  of  Mr.  Russell 
Cowans and Mr. Alex. Christmas. 
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The purposes of the following experiments were: (1) the production 
of active immunity  against  poliomyelitis by  the  least  possible num- 
ber  of  injections;  (2)  the  determination  of the minimal quantity of 
serum required to protect an animal against the  dose of virus given; 
and (3) the determination of the optimum method and time of admin- 
istration of the serum. 
Technique 
At each inoculation  the material was injected in one piqfire.  Except where 
otherwise stated, the virtts was injected into the skin, although some of it infiltrated 
more deeply.  Serum was administered  subcutaneously in one piqfire. 
Throughout these  experiments,  active  poliomyelitis  virus  was used both for 
skin and intracerebral  inoculation.  Glycerinated  cord was used,  which was ob- 
tained from animals  prostrate in 6 to 8 days after inoculation with "F1. mixed 
virus."  This virus was obtained from The Rockefeller Institute, where  it was 
developed from the passage of pooled specimens of M.A. and K. virus (14).  At 
intervals  the  potency was checked  in  this laboratory, and  it  was  found  that 
0.01 cc. of a 5 per cent glycerinated suspension produced prostration in from l0 to 
12 days.  Pooled human convalescent  serum,  which  had been collected  some 9 
months previously,  and kept at 4°C.~ was used.  Its neutralizing  power had been 
established  in monkeys.  Throughout the course of vaccination,  the animals were 
observed for mild symptoms of the disease. 
Inasmuch as Romer and Joseph (10) claimed that it took 26 days for immunity 
to develop, tests were not carried out until more than a month after the last injec- 
tion.  Control animals  received a quantity of serum equal to the largest  volume 
given  to any of the  experimental  animals.  In this way the retention  of any 
passive immunity was controlled. 
In testing the immunity, the so called  "in vitro" test was used,  by which is 
meant the ability of a serum from the test animals to neutralize  a given quantity of 
virus.  Stewart and Rhoads (7) found this procedure to be more delicate than the 
direct intracerebral inoculation  of the experimental  monkey with the virus.  It 
was  carried  out  in  the  usual  way.  Sufficient serum,  taken  from  the  treated 
animals, was added to the virus to make 1 cc., and after mixing well, incubation 
was carried  out at 37°C., for 2 hours.  The mixture was then kept overnight at 
4°C., and injected i.ntracerebrally into another animal. 
E XPEI~  ~NTAL 
.Experiment I.--A series of five mon~keys received  the equivalent of 20 to 30 
cc. of 5  per  cent  active poliomyelitis  virus emulsion,  in one or two injections. 
Actually 10 per cent, or 20 per cent suspension was given to facilitate  the injection 
of such large quantities of virus.  In Table I the equivalents of 5 per cent emulsion 
have been calculated in each case to make the figures comparable  with others in MAURICE  BRODIE  AND  ALTON  GOLDBLOOM  887 
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the literature.  The virus was administered intradermally, while the serum was 
given subcutaneously, either with, or subsequent to, the injection of the infective 
material. 
Results.--A study of Table I will show the antibody production of these animals 
against 0.05 cc. of 5 per cent active poliomyelitis cord emulsion (Neutralization 
Test 1).  The sera of four out of five animals neutralized the virus.  When the 
virus and the serum mixture of each of these was injected into another monkey, 
no symptoms occurred.  The animal which received the serum from Animal 5-7 
developed weakness of the right leg, which cleared up within 2 weeks.  Three of 
the animals, Nos. 5-0, 5-4, and 5-8, whose serum was tested against 0.1 cc. of the 
same  virus emulsions, failed to neutralize that amount (Neutralization Test 2). 
Monkey 5-7 was rendered prostrate on the 9th day after a  direct intracerebral 
inoculation of 0.05 cc. of the same virus. 
Four out of five animals failed to respond to 0.05 cc. of a  5 per cent 
suspension  of  active virus,  which  rendered  the  control prostrate in 
8  days.  It can be presumed that the fifth animal partially resisted 
the  virus,  for when  the  virus  and  serum  mixture was  injected  into 
a  monkey,  only transient  symptoms  occurred  after  an  incubation 
period of 18 days. 
Monkey 1-18 was not tested against 0.1 cc. of 5 per cent virus.  The 
remaining  three were unable  to resist  that  amount  of  cord  suspen- 
sion, as shown by Neutralization Test 2 in Table I. 
The experience with Monkey 5-7 illustrates what has already been 
cited  in  the  literature  (Aycock  and  Kagan  (6)  and  P,  hoads  (8)), 
namely,  that  the neutralization test is more sensitive for the demon- 
stration of immune bodies than direct intracerebral inoculation. 
According  to  the  above  experiments,  virus  together  with  human 
convalescent serum can produce immunity.  It was important,  there- 
fore,  to  ascertain  the  minimal  quantity  of  serum  necessary to pro- 
tect an animal against the disease during vaccination, without  inter- 
fering  with  the  immunizing  power  of  the  virus.  Therefore, with a 
fixed amount of virus, varying quantities of immune serum were used. 
Experiment II.--1 gin. of spinal cord, equivalent to 20 cc. of a 5 per cent suspen- 
sion, was emulsified in 8 cc. of distilled  water,  and administered to each of six 
monkeys intradermally  (Table  II).  The  first  received only  the  virus  intra- 
dermally.  The second and third received the virus with 2.5 cc. and 5 cc. of serum 
respectively, subcutaneously.  The fourth animal had the virus and 6 cc. of serum. 
The last two were not injected with the virus and serum at the same time.  One MAURICE BRODIE AND  ALTON GOLDBLOOM  889 
received 4 cc. of serum 4 days earlier than the virus, while the other had 6 cc. of 
serum 3 days subsequent to the virus inoculation. 
Results.--The first two animals succumbed to poliomyelitis within 9 days, while 
the third, which had been given 5 cc. of serum, fell ill on the 12th day, and was 
prostrate the 19th day.  The fourth animal, which had received 6 cc. of serum, 
resisted the disease.  The fifth animal, which had received 4 cc. of serum before 
the virus, succumbed to the disease  on the  6th  day, while  the sixth  monkey, 
which had been given 5 ec. of serum 3 days after the virus, remained well. 
The above experiment indicates that, by this method of administra- 
tion, 6 cc. of immune serum is required to protect a monkey against a 
TABLE II 
Virus  Serum  Monkey  amount  No.  __  [ amount  Combination used 
I- 
1  2.5  I 
I  5 
1  6 
1  4 
1  5 
1 
2 
3 
4 
5 
Virus intradermally 
Virus  intradermally  plus 
serum subcutaneously 
Virus  intradermally  plus  serum 
subcutaneously 
Virus  intradcrmally  plus  serum 
subcutaneously 
Serum subcutaneously.  In 4 
days--virus  intradermally 
Virus  intradermally. In  3 
days---serum  subcutane- 
ously 
Result 
days 
8--paralysis 1 arm.  9---died 
8--paralysis  right arm.  9--- 
died 
12--weakness right arm.  19 
--prostrate 
No paralysis 
4--weakness  left  arm. 
prostrate.  6--died 
No paralysis 
5-- 
Died at end of 1 month of tuberculosis--no lesions of poliomyelitis. 
gram  of virus given  intradermally.  This is  in  contradiction  to  the 
results of Rhoads (8), who injected 16 cc. of virus emulsion (0.8 gin. of 
cord)  intradermally into each of a  series of four monkeys.  None of 
his  animals  developed  the  disease.  This  discrepancy  may  be  ac- 
counted for by the manner of injection of the virus, as many piqfires 
by Rhoads,  and  as one  by us.  Thus,  in  this  work,  more  virus  in- 
filtrated the subcutaneous tissues  (on  account of the size of the dose 
given),  thereby allowing more rapid absorption and more likelihood 
of infection. 
The proportions of virus  and  serum  that  proved innocuous when 
administered simultaneously, were 6 cc. of serum to each gram of virus. 890  ACTIVE IMMUNIZATION AGAINST POLIOMYELITIS 
The next experiment was to  test  the  safety of  the  same proportions 
when the virus was given first, followed some days later by the serum 
(as indicated  by the  experience with  Monkey 6  in our Table II), or 
when the serum was given first, followed later by the virus. 
Experiment  IlL--Two monkeys (Table III) were used for this  experiment. 
The first received 1 gm. of virus, followed in 3 days by 6 cc. of serum, while the 
other was given 6 cc. of serum, and 3 days later, a gram of virus. 
Results.--Neither animal developed symptoms.  Therefore, since  we used  a 
highly active virus and whereas, as in the case of  Monkey  1-36, the virus was 
allowed to act 3 days before the serum, the administration of 6 cc. of serum with 
a gram of virus may be considered innocuous under the conditions outlined. 
The next step was to determine the effe.cts produced when the above 
method  of  administering  these  materials  was  reversed.  Therefore, 
TABLE  III 
Monkey No.  Virus 
1-36  1 
1-34  1 
l 
Serum 
cc. 
6 
6 
Method 
1 gra. virus given intradermaUy.  In 
3 days 6 cc. serum subcutaneously 
6 cc.  serum subcutaneously.  In 3 
days 1 gm. virus intradermally 
Reset 
No paralysis 
No paralysis 
Died intercurrent  infection at  the end of 4  weeks.  Histological sections 
ruled out poliomyelitis, as did a monkey transmission of cord. 
the  infective substance was injected  subcutaneously,  and  the  serum 
was given intradermally,  presuming  thereby  that  the  virus was  ab- 
sorbed more rapidly than the serum. 
Experiment IV.--One monkey was given a gram of virus subcutaneously, and 
6 cc. of serum intradermally. 
Result.--In  5  days the  animal was  paralyzed.  Therefore, the  quantities of 
virus and serum that had proved innocuous, using the former intradermally, and 
the latter Subcutaneottsly,  were infective when the virus was given subcutaneously, 
and its serum intradermally. 
Having determined that  6  cc. of  serum  given  subcutaneously  ren- 
dered the intradermal inoculation of 1 gm. of virus innocuous, the next 
step  was  to  test  the  immunizing power of virus  and  serum in  these 
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Experiment V.--Three animals, each of which was injected intradermally with a 
gram of virus made up to 8 cc. of emulsion, received 6 cc. of serum subcutaneously. 
The first received the serum 3 days before the virus inoculation, the second at the 
same  time, while the  third  received serum 3  days after the infective material. 
Again, the neutralization test was used, the serum of the treated animals being 
tested against 0.05 cc. of virus emulsion.  Not until 6 weeks after the last injection 
was the test made, thereby guarding against any residual passive immunity from 
the serum. 
TABLE  IV 
Neutralization Test 
M~k.ey 
1-34 
1-35 
#  1-36 
1-42 
1-43 
1-45 
Process of immunization 
6 cc. serum subcutaneously. 
In 3 days 1 gm. virus intra- 
cutaneously 
I  gin.  virus  intradermally. 
6 cc. serum subcutaneously 
1  gm.  virus  intradermally. 
In 3 days 6 cc. serum sub- 
cutaneously 
Control 
Control 
Control 
Virus 
s% 
¢C. 
0.05 
0.05 
0.05 
0.02 
0.02 
0.02 
~erulll 
0.95 
0.95 
0.95 
Result 
Partial  protection.  Incuba- 
tion 12 days, paralysis hind 
legs,  and  later  partial  oJ 
forearms.  Survived.  Re. 
covering 
Immune 
Immune 
9  days  weakness  right  arm 
12 days--prostrate 
8  days  weakness  right  arm 
10  days--prostrate 
12 days prostrate 
Neutralization tests carried out 5 weeks after completion of course of vaccina- 
tion. 
Died at the end of 4 weeks of intercurrent infection. 
Results.--(Table  IV.)  The  serum  of Animal  1-34,  which  received serum 
first and  the  virus  later, gave doubtful protection.  The test animal developed 
complete paralysis of the hind limbs, and partial of the upper extremities, but 
survived,  and  is  recovering.  The other two monkeys resisted the virus.  The 
controls succumbed in from 10 to 12 days to 0.02 cc. of this virus emulsion. 
In this small series, serum given subcutaneously with or after the in- 
jection of virus,  was  more  effective than  when  the  serum  was  given 
first.  Moreover,  a  gram  of virus with 6  cc. of serum administered in 
either of the more effective ways (i.e., virus and serum simultaneously, 892  ACTIVE  IMMUNIZATION  AGAINST  POLIOMYELITIS 
or serum 3  days after virus)  induced sufficient immunity to resist 
two  and  one-half times the dose of virus that  paralyzed  the  con- 
trol animals.  With specimens of this virus, infection had been pro- 
duced with doses as small as 0.01 cc. of a 5 per cent suspension. 
Immunity is a relative thing, and none is probably so  great that it 
cannot be broken down by a large amount of virus.  Indeed, Aycock 
and Kagan (6) have reproduced poliomyelitis in animals by using,  at 
a second injection, large amounts of virus.  Therefore, an immunity 
to several lethal doses may be considered definite, and perhaps useful. 
In the two series, immunization was carried out on eight animals. 
Six of these resisted 0.05 cc. of 5  per cent virus emulsion,  and the 
other two  partially  resisted  as  indicated  by  the  prolonged  incu- 
bation period and the milder attack in the test animals, as compared 
with the controls.  Using larger amounts of virus, Rhoads  (13) did 
not obtain as complete immunity, for only half of his monkeys resisted 
0.01  cc.  of  a  5  per  cent  filtrate.  However, he  used  more  serum 
in proportion to virus, and in addition combined them.  In this way 
he had complete neutralization as checked by intracerebral test. 
Todd (15), Andrewes (16),and Long and Olitsky (17), using vaccine 
virus,  and  Schultz  et al.  (18) and  Olitsky  et  al.  (19) poliomyelitis 
virus, have shown that neutralization of the virus with immune serum 
does not destroy the virus.  Yet, the fact that virus can be recovered 
from a combination with its serum, is no indication that such a mixture 
always dissociates  sufficiently in  the body to  immunize efficiently. 
Only when the serum is not in excess is this possible.  This has been 
pointed out by Zinsser and Tang (20), who produced active immuniza- 
tion  against herpes virus with virus  emulsion and  immune serum. 
They concluded as follows:  "Active immunity can be attained only 
when some degree of reaction to the living virus has occurred.  Rab- 
bits which survived neutralized serum-virus mixtures did not acquire 
immunity."  Similarly Rhoads (21) used vaccine virus with immune 
serum, in rabbits, in such quantities as were innocuous intradermally. 
He found that an excessive amount of immune serum rendered the 
mixtures ineffective.  Therefore, by using less  serum than  R_hoads, 
and yet sufficient  to render the  procedure safe,  a  greater degree of 
immunization has been obtained by us. M.AURICE BRODIE AND  ALTON GOLDBLOOM  893 
CONCLUSIONS 
1.  A combination of poliomyelitis virus and specific human serum 
is effective for the production of active immunity. 
2.  For each gram of active virus given intradermally as an emul- 
sion, 6 cc. of human immune serum, injected subcutaneously, was re- 
quired in our experiments to protect a monkey from paralysis.  Some 
degree of active immunity was induced. 
3.  Immunity, without symptoms of ~e disease, was secured when 
the serum was given at the time of inoculation, or within 3 days pre- 
ceding or following inoculation of the virus. 
4.  For the production of immunity, virus, preceded by serum ad- 
ministration, is probably less effective than when it is given simulta- 
neously with, or before, the injection of serum. 
5.  The virus neutralization test is more sensitive than the direct 
intracerebral test for determining the production of immunity. 
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